Acetamiprid and flupyradifurone are approved in some countries but remain highly controversial. Farming groups support their use to stay competitive, while many scientists and environmental advocates warn of risks to biodiversity and possible cancer concerns. Last year, a petition against their approval gathered two million signatures.